InvestorsHub Logo

sentiment_stocks

11/26/23 11:25 AM

#650716 RE: Lykiri #650713

Exactly! As you point out… he even asked the question and got the answer! Over the years, I’ve noted (and written it on this board) how he would never mention DCVax-L as a promising treatment when he was interviewed or wrote about GBM and future treatments on the horizon. When he was at NYAS and acting all congratulatory … I thought maybe he’d turned a page, and/or that perhaps I’d been wrong in my assessment of him… but no, I was right… but I really do wish that I’d been wrong.

Horseb4CarT

11/26/23 2:37 PM

#650752 RE: Lykiri #650713

Although false negative narratives need to be debunked, the results of the ph3 trial have been published in the peer reviewed JAMA-Oncology and Dr Bosch’s method of operation presentation and its data explains how and why DCVax works, and increasing medical papers and findings are accumulating support.

All the boxes have been checked and prerequisites satisfied for MAA submission to the MHRA, and for the other RAs, and the breakthrough results with excellent safety profile that only helps while doing no harm, exceedingly calls for approval. The costs are also favorable.

It’s happening!!!

Doc logic

11/26/23 5:13 PM

#650797 RE: Lykiri #650713

Lykiri,

You found the smoking gun!; ). Thanks for sharing. Best wishes.